Reflections on treatment of COVID-19 with traditional Chinese medicine

被引:81
作者
Luo, Hua [1 ]
Gao, Yan [1 ]
Zou, Jian [1 ]
Zhang, Siyuan [1 ]
Chen, Hanbin [1 ]
Liu, Qiao [1 ]
Tan, Dechao [1 ]
Han, Yan [1 ]
Zhao, Yonghua [1 ]
Wang, Shengpeng [1 ]
机构
[1] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
关键词
COVID-19; Coronavirus; Traditional Chinese medicine; Prescriptions; QINGFEI PAIDU DECOCTION; NETWORK PHARMACOLOGY; HERBAL MEDICINE; MECHANISM; TANG;
D O I
10.1186/s13020-020-00375-1
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Coronavirus disease 2019 (COVID-19) pandemic is spreading rapidly around the globe. By the establishment of an integrative system combining both traditional Chinese medicine (TCM) and western medicine, China has achieved good clinical efficacy in the prevention and control of the pandemic. The advantages of TCM in the treatment of COVID-19 include effective relief of symptoms, retarding the development from mild and moderate to severe, improvement of cure rate, reducing death rates, and promotion of rehabilitation. Besides, according to the different severity levels of individual cases, the National Health Commission of the People's Republic of China issued treatment guidelines that provide corresponding prescriptions for patients. From the perspective of TCM, this review aims to analyze the role of a variety of TCM prescriptions in the treatment of COVID-19, focusing on the analysis of the "Three TCM prescriptions and three medicines" recommended by the Chinese authorities during the pandemic. We expect that this review will provide insights into the prevention and treatment of COVID-19 with TCM.
引用
收藏
页数:14
相关论文
共 109 条
[91]  
Yang X, 2020, MOD CHIN MED, P1
[92]  
You Yan-nan, 2020, Drug Evaluation Research, V43, P613, DOI 10.7501/j.issn.1674-6376.2020.04.005
[93]  
Zhang CL., 2014, Chin J Exp Clin Infect Dis (Electronic Edition), P360, DOI [10.3877/cma.j.issn.1674-1358.2013.03.014, DOI 10.3877/CMA.J.ISSN.1674-1358.2013.03.014]
[94]   Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target [J].
Zhang, Haibo ;
Penninger, Josef M. ;
Li, Yimin ;
Zhong, Nanshan ;
Slutsky, Arthur S. .
INTENSIVE CARE MEDICINE, 2020, 46 (04) :586-590
[95]  
Zhang L, 2018, DOCTOR, V3, P141
[96]   The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson?s Disease [J].
Zhang, Lingyu ;
Zhang, Liping ;
Li, Yanwei ;
Li, Lin ;
Melchiorsen, Josefine Ulrikke ;
Rosenkilde, Mette ;
Holscher, Christian .
JOURNAL OF PARKINSONS DISEASE, 2020, 10 (02) :523-542
[97]   iTRAQ-based quantitative proteomic analysis reveals Bai-Hu-Tang enhances phagocytosis and cross-presentation against LPS fever in rabbit [J].
Zhang, Shidong ;
Wang, Dongsheng ;
Dong, Shuwei ;
Yang, Zhiqiang ;
Yan, Zuoting .
JOURNAL OF ETHNOPHARMACOLOGY, 2017, 207 :1-7
[98]   Data-driven predictive models for chemical durability of oxide glass under different chemical conditions [J].
Zhang, Yi ;
Li, Aize ;
Deng, Binghui ;
Hughes, Kelleen K. .
NPJ MATERIALS DEGRADATION, 2020, 4 (01)
[99]   Graphene-coated Au nanoparticle-enhanced Raman spectroscopy [J].
Zhang, Yue-Jiao ;
Chen, Qing-Qi ;
Chen, Xing ;
Wang, An ;
Tian, Zhong-Qun ;
Li, Jian-Feng .
JOURNAL OF RAMAN SPECTROSCOPY, 2021, 52 (02) :439-445
[100]  
[赵静 Zhao Jing], 2020, [中草药, Chinese Traditional and Herbal Drugs], V51, P829